| Original language | English |
|---|---|
| Pages (from-to) | 577-578 |
| Number of pages | 2 |
| Journal | Progress in Neuro-Psychopharmacology and Biological Psychiatry |
| Volume | 33 |
| Issue number | 3 |
| DOIs | |
| State | Published - 30 Apr 2009 |
Bibliographical note
Funding Information:This work was supported by a grant from the Medical Research Center, Korea Science and Engineering Foundation, Republic of Korea (R13-2002-005-04001-0).
Funding Information:
Dr. Pae has received research grant from GlaxoSmithKline Korea, GlaxoSmithKline, AstraZeneca Korea, Janssen Pharmaceuticals Korea, Eli Lilly and Company Korea, Korean Research Foundation, Otsuka Korea Pharmaceuticals, Wyeth Korea, Catholic Medical Center, and Korean Institute of Science and Technology Evaluation and Planning; has received honoraria and is on the speaker's bureaus of GlaxoSmithKline Korea, Lundbeck Korea, AstraZeneca Korea, Janssen Pharmaceuticals Korea, Eli Lilly and Company Korea, McNeil Consumer and Specialty Inc, and Otsuka Korea Pharmaceuticals, Inc.